Stocks and Investing Stocks and Investing
Mon, August 12, 2024

Terence Flynn Maintained (ABBV) at Buy with Increased Target to $218 on, Aug 12th, 2024


Published on 2024-10-28 13:33:18 - WOPRAI, Terence Flynn
  Print publication without navigation


Terence Flynn of Morgan Stanley, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $211 to $218 on, Aug 12th, 2024.

Terence has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 0 agree with Terence's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Terence


  • Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $200 on, Monday, August 5th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $205 on, Friday, July 26th, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Increased Target to $200 on, Friday, July 26th, 2024
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy with Increased Target to $210 on, Friday, July 26th, 2024
  • Evan David Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $214 on, Friday, July 19th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy and Held Target at $190 on, Tuesday, July 2nd, 2024
  • Rajesh Kumar of "HSBC" Upgraded from Hold to Strong Buy and Held Target at $185 on, Wednesday, June 5th, 2024
Contributing Sources